drugset / Trial / NCT05107921

Bromfenac Sodium Hydrate Eye Drops in Familial Exudative Vitreoretinopathy

NCT05107921

Phase 2 Unknown 39 enrolled Seoul National University Hospital
NaSingle-groupOpen-labelTreatment

Summary

This study aims to investigate the efficacy and safety of bromfenac sodium hydrate eye drops in patients with familial exudative vitreoretinopathy receiving diode laser photocoagulation.

Timeline

Start
2021-11-01
Primary completion
2024-10-20
Completion
2024-10-20

Drugs

EvaluationDrugModalityDoseRoute
Subject Bromfenac Other / unclassified Other